Vanda Pharmaceuticals Inc. (VNDA) Fundamentals

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improves the lives of patients. Its commercial portfolio comprises two products, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) and nighttime sleep disturbances in Smith-Magenis Syndrome (SMS) and Fanapt for the treatment of schizophrenia. Its other products include Tradipitant (VLY-686), VTR-297, and VQW-765.
SHARE INFORMATION
Market Cap$ 552,605,484
Shares Outstanding56,561,462
Float45,301,588
Percent Float80.09%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 268,682,000
Latest Fiscal EPS$ 0.58
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions483
Institutional Holdings Date2022-08-31
Institutional Bought Previous 3 Months7,473,993
Institutional Holdings Percent177.2%
Institutional Sold Previous 3 Months7,797,534
Insider Holdings Date2022-08-31
Insider Bought Previous 3 Months178,102
Insider Holdings Percent5.2
Insider Sold Previous 3 Months61,035
Insider Shares Owned2,927,794
TRADING INFO
52 Week High$ 21.44
52 Week Low$ 9.24
52 Week High Change$ -42.50
21 Day Moving Average$ 10.03
21 Day Extended Moving Average$ 9.9631
50 Day Moving Average$ 10.3492
50 Day Extended Moving Average$ 10.2422
200 Day Moving Average$ 11.7021
200 Day Extended Moving Average$ 11.7433
10 Day Average Volume429,214
20 Day Average Volume401,197
30 Day Average Volume411,348
50 Day Average Volume391,824
Alpha-0.003564
Beta0.4680
Standard Deviation0.133819
R20.031135
7 Day Price Change$ 0.07
7 Day Percent Change0.72%
21 Day Price Change$ -0.43
21 Day Percent Change-4.22%
30 Day Price Change$ -0.68
30 Day Percent Change-6.51%
Month to Date Price Change$ -0.81
Month to Date Percent Change-7.66%
Quarter to Date Price Change$ -1.13
Quarter to Date Percent Change-10.37%
180 Day Price Change$ -2.03
180 Day Percent Change-17.2%
200 Day Price Change$ -1.37
200 Day Percent Change-12.3%
Year to Date Price Change$ -5.92
Year to Date Percent Change-37.73%

Vanda Pharmaceuticals Inc. (VNDA) Key Ratios

PROFITABILITY
EBIT Margin5.8%
EBITDA Margin6.9%
Pre-Tax Profit Margin8.4%
Profit Margin Count4.17%
Gross Margin90.6%
Profit Margin TOT4.17%
INCOME STATEMENTS
Revenue$ 262,696,000
Revenue Per Share$ 4.6444
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book1.10
Total Debt To Equity0.00
Int Coverage0.00
Current Ratio5.60
Leverage Ratio1.20
Quick Ratio5.30
Long Term Debt To Capital0.02
VALUATION MEASURES
PE Ratio49.50
Enterprise Value$ 130,065,859
Price to Sales2.1036
Price to Free Cash12.30
PE High Last 5 Years65.20
Price To Book1.10
Price To Cash Flow12.30
PE Low Last 5 Years-40.40
Price to Tangible Book1.10
MANAGEMENT EFFECTIVENESS
Receivables Turnover9.20
Invoice Turnover19.30
Assets Turnover0.50
Return Assets1.98
Return on Equity2.35
Return on Capital2.17

Vanda Pharmaceuticals Inc. (VNDA) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorPricewaterhouseCoopers LLP
CEOMihael Hristos Polymeropoulos
Emplyoees278
Last AuditUQ
CIK0001347178
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address2200 Pennsylvania Avenue NW
Suite 300 E
Washington, DC 20037
Websitehttps://www.vandapharma.com
Facsimile+1 202 296-1450
Telephone+1 202 734-3400
Emailjim.kelly@vandapharma.com


Your Recent History
NASDAQ
VNDA
Vanda Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.